Skip to main content

About Adriano Rossi

Prof Adriano Rossi, Editor-in-Chief

Prof Rossi obtained a BSc (Hons) and PhD (under the supervision of Drs Euan MacIntyre and Rodger McMillan) in the Department of Pharmacology at the University of Glasgow. He then carried out postdoctoral research at Wake Forest University, Winston-Salem, North Carolina, USA in Professor Joseph O’Flaherty’s laboratory. When he returned to the UK he was awarded a Wellcome Trust Post-Doctoral grant that led to a lectureship in Professor Tim William’s department at the National Heart & Lung Institute, University of London. He subsequently joined Professor Chris Haslett’s Respiratory Medicine Unit at the University of Edinburgh as an MRC funded senior scientist. He currently holds a Personal Chair in Respiratory and Inflammation Pharmacology in the MRC Centre for Inflammation Research at the Queen’s Medical Research Institute at the University of Edinburgh. He was awarded a DSc from the University in 2010 and is a Fellow of the Society of Biology and a Fellow of the British Pharmacological Society.

His research involves investigating the cellular processes and signalling mechanisms controlling inflammation with a focus on understanding inflammation resolution especially the mechanisms regulating apoptosis and phagocyte recognition and phagocytosis of apoptotic cells. He has published over 180 articles in peer-reviewed journals, reviews and book chapters and has held several major research grants. He believes that his team will provide the scientific foundation for innovative approaches for the therapy of human inflammatory diseases.

New Content Item

Affiliated with the British Inflammation Research Association (BIRAs).

Annual Journal Metrics

  • 2022 Citation Impact
    5.1 - 2-year Impact Factor
    5.1 - 5-year Impact Factor
    1.199 - SNIP (Source Normalized Impact per Paper)
    1.259 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    113 days submission to accept (Median)

    2023 Usage 
    675 Altmetric mentions